Review: Incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer

Daphne Hompes (1) , Theo Ruers (1)

1 Department of Surgery

This review describes the extent, frequency and clinical importance of Bevacizumab(BV)-related serious adverse events (SAE) after surgery, during or after chemotherapy with BV in patients with metastatic colorectal cancer (mCRC).

Mots clés: Metastatic colorectal cancer; bevacizumab; complications; surgical; non-surgical

Daphne Hompes, Theo Ruers. Review: Incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer. EJSO - European Journal of Surgical Oncology, 2011, 37 (9), pp.737. ⟨10.1016/j.ejso.2011.06.004⟩. ⟨hal-00723460⟩